Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,442,118
-
Share change
-
+236,602
-
Total reported value
-
$3,732,798,700
-
Put/Call ratio
-
45%
-
Price per share
-
$126.79
-
Number of holders
-
171
-
Value change
-
+$29,316,659
-
Number of buys
-
86
-
Number of sells
-
72
Institutional Holders of KARUNA THERAPEUTICS INC - COM (KRTX) as of Q1 2022
As of 31 Mar 2022,
KARUNA THERAPEUTICS INC - COM (KRTX) was held by
171 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,442,118 shares.
The largest 10 holders included
FMR LLC, ARCH Venture Management, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Sofinnova Investments, Inc., BlackRock Inc., STATE STREET CORP, VIKING GLOBAL INVESTORS LP, WELLINGTON MANAGEMENT GROUP LLP, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
171
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.